Skip to main content
SpringerPlus

Table 4 Multivariate analysis of clinical factors associated to mpMRI reliability

From: Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy

 

OR

95 % CI

p-value

PSA <10

Reference

  

PSA 10–20

0.43

(0.03–5.05)

0.50

PSA >20

0.61

(0.04–8.21)

0.70

Gleason ≤6a

Reference

  

Gleason ≥7

1.39

(0.41–4.65)

0.58

ppb <50 %

Reference

  

ppb ≥50 %

1.07

(0.31–3.69)

0.90

Age

0.92

(0.84–1.00)

0.06

  1. ppb positive prostate biopsies
  2. aNo significant differences were found when considering Gleason ≤6 and Gleason = 7 (3 + 4) compared to the rest of Gleason score. Similar lack of significant differences were observed when Gleason = 6 was compared to Gleason = 7 or Gleason = 8–10
Back to article page